Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data
September 29, 2023 at 12:02 PM EDT
Structure's pill is part of the same class of drugs as Novo Nordisk's blockbuster diabetes drug Ozempic and weight loss counterpart Wegovy.
